factor xa - Robuta Search

https://www.ncbi.nlm.nih.gov/Structure/pdb/1NFY 1NFY: CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095 Coagulation factor XA, heavy chainCoagulation factor XA, light... crystal structure factor xa human https://pubchem.ncbi.nlm.nih.gov/bioassay/1845147 AID 1845147 - Peptidase, Factor Xa Eurofins-Panlabs enzyme assay - PubChem BioAssay record AID 1845147 submitted by ChEMBL: Peptidase, Factor Xa Eurofins-Panlabs enzyme assay. factor xa enzyme assay aid peptidase eurofins https://publikationen.uni-tuebingen.de/xmlui/handle/10900/41645 Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban... factor xa management intravascular coagulopathy https://www.ncbi.nlm.nih.gov/Structure/pdb/1KSN 1KSN: Crystal Structure of Human Coagulation Factor XA Complexed with FXV673 COAGULATION FACTOR XACALCIUM IONMETHYL-3-(4'-N-OXOPYRIDYLPHENOYL)-3-METHYL-2-(M-AMIDINOBENZYL)-PROPIONATE crystal structure factor xa human https://pmc.ncbi.nlm.nih.gov/articles/PMC4321604/ The role of factor Xa inhibitors in venous thromboembolism treatment - PMC Three factor Xa inhibitors have been studied in the treatment of venous thromboembolism, both for acute therapy and as extended therapy to prevent recurrent... factor xa inhibitors the role venous thromboembolism https://my.clevelandclinic.org/health/treatments/24745-factor-xa-inhibitors Factor Xa Inhibitors: How They Work & Side Effects Factor Xa inhibitors are anticoagulants (blood thinners) that treat and prevent blood clots. They block a protein your body needs to make a clot. factor xa inhibitors how they work side effects https://pubmed.ncbi.nlm.nih.gov/22186946/?dopt=Abstract Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with... Edoxaban, an oral, direct factor Xa inhibitor, has a similar or low incidence of bleeding events compared with other anticoagulants in clinical trials.... https://pubmed.ncbi.nlm.nih.gov/31133411/ Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with... efficacy and safety https://research.monash.edu/en/publications/determination-of-the-p1-p2-and-p3-subsite-specificity-of-factor-x/ Determination of the P'1, P'2 and P'3 subsite-specificity of factor Xa - Monash University https://pubmed.ncbi.nlm.nih.gov/30985986/?dopt=Abstract An assay to measure levels of factor Xa inhibitors in blood and plasma The assay is ideal for rapidly and accurately measuring DOAC levels in plasma and blood, demonstrating its potential for point-of-care applications. factor xa inhibitors https://pure.psu.edu/en/publications/occurrence-of-o-linked-xyl-glcnac-and-xyl-glc-disaccharides-in-tr/ Occurrence of O-linked Xyl-GlcNAc and Xyl-Glc disaccharides in trocarin, a factor Xa homolog from... https://blogs.nejm.org/cardioexchange/2013/11/25/fda-spanks-23andme-grants-breakthrough-status-to-factor-xa-inhibitor-and-approves-promus-premier-stent/ FDA Reprimands 23andMe, Grants Breakthrough Status to Factor Xa Inhibitor, and Approves Promus... https://scholarworks.indianapolis.iu.edu/items/5ab7d240-1b48-41c2-9e58-0d941ec65193/request-a-copy?bitstream=87d36732-75d5-4789-b420-fb4242450e4b Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for... Background: People undergoing major orthopaedic surgery are at increased risk of postoperative thromboembolic events. Low molecular weight heparins (LMWHs) are... https://pubmed.ncbi.nlm.nih.gov/37063756/ Four-factor prothrombin complex concentrate for the treatment of oral factor Xa... A fixed-dosing strategy appears to be a safe and effective alternative to variable weight-based dosing and was associated with lower 4F-PCC usage. However,... for the four factor complex concentrate https://kth.diva-portal.org/smash/record.jsf?pid=diva2%3A1716653 Binding modes of prothrombin cleavage site sequences to the factor Xa catalytic triad : Insights... https://pubmed.ncbi.nlm.nih.gov/30828771/ Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with... EudraCT 2016-003024-23. factor xa inhibitors https://nrc-publications.canada.ca/eng/view/object/?id=f0190636-b8e2-4add-b146-88a5fe2a4d64 Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa... Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa https://kth.diva-portal.org/smash/record.jsf?pid=diva2:1716653 Binding modes of prothrombin cleavage site sequences to the factor Xa catalytic triad : Insights... https://pubmed.ncbi.nlm.nih.gov/19470889/ Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy... We observed a dose-related increase in bleeding and a trend toward a reduction in ischemic events with the addition of apixaban to antiplatelet therapy in... https://www.techtransfer.nih.gov/patent/e-063-1991-0-pct-02 METHOD FOR EVALUATING CONTRIBUTIONS OF EXTRINSIC AND INTRINSIC COAGULATION FACTORS TO A FACTOR Xa... https://nrc-publications.canada.ca/fra/voir/objet/?id=c0eaf1a1-ee12-4b88-bba3-0ebb0cb59fee Plasminogen binds plasmin-modulated factor Xa by Ca2+- and C-terminal lysine-dependent and... Plasminogen binds plasmin-modulated factor Xa by Ca2+- and C-terminal lysine-dependent and -independent interactions. https://www.newswire.ca/news-releases/servier-canada-enters-into-an-agreement-with-daiichi-sankyo-for-factor-xa-inhibitor-edoxaban-584511871.html Servier Canada enters into an agreement with Daiichi Sankyo for factor Xa Inhibitor Edoxaban /CNW Telbec/ - Servier Canada is pleased to announce the signing of a strategic agreement with Daiichi Sankyo Co., Limited (TSE: 4568). Under this agreement,... https://experts.umn.edu/en/publications/selective-inhibition-of-factor-xa-is-more-efficient-than-factor-v/ Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade... https://pmc.ncbi.nlm.nih.gov/articles/PMC11770845/ Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for... People undergoing major orthopaedic surgery are at increased risk of postoperative thromboembolic events. Low molecular weight heparins (LMWHs) are recommended... https://scholars.okstate.edu/en/publications/harms-reporting-assessment-regarding-systematic-reviews-focusing-/ Harms reporting assessment regarding systematic reviews focusing on direct oral factor Xa... systematic reviews